Testosterone deficiency: A determinant of aortic stiffness in men

Atherosclerosis

Volumn 233, Issue 1, 2014, Pages 278-283

  Vlachopoulos, Charalambos ^a   Ioakeimidis, Nikolaos ^a   Miner, Martin ^b   Aggelis, Athanassios ^a   Pietri, Panagiota ^a   Terentes Printzios, Dimitrios ^a   Tsekoura, Dorothea ^a   Stefanadis, Christodoulos ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b MIRIAM HOSPITAL   (United States)

Author keywords

Carotid femoral pulse wave velocity; Testosterone deficiency; Total testosterone

Indexed keywords

CAROTID-FEMORAL PULSE WAVE VELOCITY; TESTOSTERONE DEFICIENCY; TOTAL TESTOSTERONE;

ADULT; AGED; BLOOD PRESSURE; CAROTID ARTERIES; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; TESTOSTERONE; VASCULAR STIFFNESS;

EID: 84893819088     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.12.010     Document Type: Article

References (45)

1. Kaushik M., Sontineni S.P., Hunter C. Cardiovascular disease and androgens: a review. Int J Cardiol 2010, 142(1):8-14.
2. Kelly D.M., Jones T.H. Testosterone: a vascular hormone in health and disease. JEndocrinol 2013, 217(3):R47-R71.
3. Ruige J.B., Mahmoud A.M., De Bacquer D., Kaufman J.M. Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart 2011, 97:870-875.
4. Corona G., Rastrelli G., Monami M., et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol 2011, 165:687-701.
5. Vlachopoulos C., Ioakeimidis N., Terentes-Printzios D., et al. Plasma total testosterone and incident cardiovascular events in hypertensive patients. Am J Hypertens 2013, 26(3):373-381.
6. Feldman H.A., Longcope C., Derby C.A., et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. JClin Endocrinol Metab 2002, 87(2):589-598.
7. Fogari R., Zoppi A., Preti P., et al. Sexual activity and plasma testosterone levels in hypertensive males. Am J Hypertens 2002, 15(3):217-221.
8. O'Rourke M.F., Vlachopoulos C. McDonald's blood flow in arteries: theoretical, experimental and clinical principles 2011, Edward Arnold, London. 6th ed.
9. Laurent S., Cockcroft J., Van Bortel L., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588-2605.
10. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. JAm Coll Cardiol 2010, 55(13):1318-1327.
11. Vlachopoulos C., Aznaouridis K., O'Rourke M.F., Safar M.E., Baou K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010, 31(15):1865-1871.
12. Mitchell G.F., Hwang S.J., Vasan R.S., et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010, 121(4):505-511.
13. Laurent S., Boutouyrie P., Asmar R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001, 37:1236-1241.
14. Blacher J., Guerin A.P., Pannier B., Marchais S.J., Safar M.E., London G.M. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999, 99:2434-2439.
15. Mancia G., Fagard R., Narkiewicz K., et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013, 34(28):2159-2219.
16. Mattace-Raso F., Hofman A., Verwoert G.C., et al. The Reference Values for Arterial Stiffness' Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 2010, 31(19):2338-2350.
17. Dockery F., Bulpitt C., Donaldson M., Fernandez S., Rajkumar C. The relationship between androgens and arterial stiffness in older men. JAm Geriatr Soc 2003, 51:1627-1632.
18. Canpolat U., Tokgözoǧlu L., Aydin K., et al. Impaired aortic elastic properties in patients with adult-onset hypogonadism 2013, vol. 22:114-119. Blood Press.
19. Fukui M., Ose H., Kitagawa Y., et al. Relationship between low serum endogenous androgen concentrations and arterial stiffness in men with type 2 diabetes mellitus. Metab Clin Exp 2007, 56:1167-1173.
20. Smith JC, Bennett S, Evans LM, etal. The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab;86:4261-7.
21. Kyriazis J., Tzanakis I., Stylianou K., et al. Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients. Nephrol Dial Transplant 2011, 26:2971-2977.
22. Perk J., De Backer G., Gohlke H., et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012, 33:1635-1701.
23. Van Bortel L.M., Laurent S., Boutouyrie P., et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. JHypertens 2012, 30(3):445-448. Artery Society, European Society of Hypertension Working Group on Vascular Structure and FunctionEuropean Society of Hypertension Working Group on Vascular Structure and Function, European Network for Noninvasive Investigation of Large ArteriesEuropean Network for Noninvasive Investigation of Large Arteries.
24. Wang C., Nieschlag E., Swerdloff R., et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol 2009, 55:121-130.
25. Traish A.M., Miner M.M., Morgentaler A., Zitzmann M. Testosterone deficiency. Am J Med 2011, 124:578-587.
26. Hougaku H., Fleg J.L., Najjar S.S., et al. Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. Am J Physiol Endocrinol Metab 2006, 290:E234-E242.
27. Muller M., van den Beld A.W., Bots M.L., Grobbee D.E., Lamberts S.W., van der Schouw Y.T. Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 2004, 109:2074-2079.
28. Price J.F., Lee A.J., Fowkes F.G. Steroid sex hormones and peripheral arterial disease in the Edinburgh Artery Study. Steroids 1997, 62:789-794.
29. Tedeschi-Reiner E., Ivekovic R., Novak-Laus K., Reiner Z. Endogenous steroid sex hormones and atherosclerosis of retinal arteries in men. Med Sci Monit 2009, 15(5):CR211-CR216.
30. Yarnell J.W., Beswick A.D., Sweetnam P.M., Riad-Fahmy D. Endogenous sex hormones and ischemic heart disease in men. The Caerphilly Prospective Study. Arterioscler Thromb 1993, 13:517-520.
31. Nehra A., Jackson G., Miner M., et al. The Princeton III consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2012, 87:766-778.
32. Miner M., Seftel A.D., Nehra A., et al. Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes. Am Heart J 2012, 164:21-28.
33. Vlachopoulos C., Jackson G., Stefanadis C., Montorsi P. Erectile dysfunction in the cardiovascular patient. Eur Heart J 2013, 34(27):2034-2046.
34. Nelson M.R., Stepanek J., Cevette M., Covalciuc M., Hurst R.T., Tajik A.J. Noninvasive measurement of central vascular pressures with arterial tonometry: clinical revival of the pulse pressure waveform?. Mayo Clin Proc 2010, 85(5):460-472.
35. Vlachopoulos C. Progress towards identifying biomarkers of vascular aging for total cardiovascular risk prediction. JHypertens 2012, 30(Suppl:S19-26).
36. Carson C.C., Rosano G. Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data. JSex Med 2012, 9(1):54-67.
37. Shores M., Smith N., Forsberg C., Anawalt B., Mathumoto A. Testosterone replacement therapy and mortality in men with low testosterone levels. JClin Endocrinol Metab 2012, 97(6):2050-2058.
38. Basaria S., Coviello A.D., Travison T.G., et al. Adverse events associated with testosterone administration. NEngl J Med 2010, 363(2):109-122.
39. Vigen R., O'Donnell C.I., Barón A.E., et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAm Med Assoc 2013, 310(17):1829-1836.
40. Miner M.M. Men's health in primary care: an emerging paradigm of sexual function and cardiometabolic risk. Urol Clin North Am 2012, 39(1):1-23.
41. Buvat J., Maggi M., Guay A., Torres L.O. Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. JSex Med 2013, 10:245-284.
42. Saad F., Haider A., Doros G., Traish A. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obes (Silver Spring) 2013, 21(10):1975-1981.
43. Kupelian V., Chiu G.R., Araujo A.B., Williams R.E., Clark R.V., McKinlay J.B. Association of sex hormones and C-reactive protein levels in men. Clin Endocrinol (Oxf) 2010, 72:527-533.
44. Bartlett D.B., Firth C.M., Phillips A.C., et al. The age-related increase in low-grade systemic inflammation (inflammaging) is not driven by cytomegalovirus infection. Aging Cell 2012, 11:912-915.
45. Vlachopoulos C., Dima I., Aznaouridis K., et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 2005, 112:2193-2200.